Fundraising Fox
ポル・メド・テック
Kawasaki, JP · 2 known investors
Find your way into ポル・メド・テック
Sign up to see every warm intro you have to ポル・メド・テック
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ポル・メド・テック team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PorMedTec develops transplantable organs and tissues using genetically modified pigs for manufacturing and commercializing as regenerative medicine products. The company targets patients and healthcare systems facing severe organ shortages by providing alternatives to dialysis and other symptom-based treatments.
Founders & leadership
HN
Hiroshi NagashimaFounder, CEO and Chief Scientist
GM
Genjiro MiwaFounder, President and CEO
Investors · 2
Frequently asked questions
- What does ポル・メド・テック do?
- PorMedTec develops transplantable organs and tissues using genetically modified pigs for manufacturing and commercializing as regenerative medicine products. The company targets patients and healthcare systems facing severe organ shortages by providing alternatives to dialysis and other symptom-based treatments.
- Who founded ポル・メド・テック?
- ポル・メド・テック was founded by Hiroshi Nagashima, Genjiro Miwa.
- Who are ポル・メド・テック's investors?
- ポル・メド・テック's investors include Eight Roads Ventures, Global Brain.
- Where is ポル・メド・テック headquartered?
- ポル・メド・テック is headquartered in Kawasaki, JP.